Please login to the form below

Lupus Awareness Month

In this second October’s blog, we will be looking into Lupus in clinical trials: its symptoms, complications, treatments, incidence and focus on diversity.

October marks Lupus Awareness month in which education and awareness of lupus is brought to light  through several initiatives. Lupus is an autoimmune disease as it causes the immune system to attack healthy cells in the body.

It has been long established that 90% of individuals with lupus are women, with the illness being up to three times more prevalent in women of colour than Caucasian women. Moreover, Lupus has been previously ranked amongst the top 20 causes of death in all women, however this figure rose to distressing new levels as lupus is now recognized as the 5th and 6th leading cause of death among Black and Hispanic women aged 15-34.

Read the full blog here

12th October 2021



Company Details

Innovative Trials

+44 (0) 1707 378 581

Contact Website

Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
United Kingdom

Latest content on this profile

Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Innovative Trials
Innovative Trials on the latest ABPI report
Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Innovative Trials
Innovative Trials featuring in a Clinical Trials Arena article
Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Innovative Trials
Overcoming Patient Recruitment Challenges in Rare Disease Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments.We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market.With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will:explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trialshear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials.Learning ObjectivePatient recruitment challenges in rare disease studiesChallenges in sickle cells studiesFamily/Patient perspectiveAccelerating patient recruitment in rare disease studiesSpeaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative TrialsSpeaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease)Speaker 3 - Margaret Alege - Patient
Innovative Trials
FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials
Innovative Trials and Pfizer invite you to attend the live webinar
Innovative Trials
Innovative Trials opens first US office
We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press release here: Innovative Trials website: Follow our social media. LinkedIn: Instagram: Twitter: Facebook:
Innovative Trials